Mercer Global Advisors
NAGE

Mercer Global Advisors’s Niagen Bioscience NAGE Stock Holding History

Mercer Global Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181K Buy
40,966
+16,412
+67% +$88.6K ﹤0.01% 2875
2025
Q4 		$156K Buy
24,554
+831
+4% +$5.78K ﹤0.01% 2635
2025
Q3 		$221K Buy
23,723
+3,000
+14% +$30.3K ﹤0.01% 2316
2025
Q2 		$299K Buy
20,723
+2,583
+14% +$25.5K ﹤0.01% 1851
2025
Q1 		$125K Buy
18,140
+8,140
+81% +$51.1K ﹤0.01% 2033
2024
Q4 		$53K Buy
+10,000
New +$54.7K ﹤0.01% 2081
2024
Q2 		– Sell
-10,000
Closed -$35K – 2057
2024
Q1 		$35K Buy
+10,000
New +$18.5K ﹤0.01% 1907
2023
Q4 		– Sell
-10,000
Closed -$15K – 2102
2023
Q3 		$15K Buy
+10,000
New +$15.6K ﹤0.01% 1934

Other funds holding NAGE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return